[Form 4] Carter Bankshares, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Matthew M. Speare, SEVP and Chief Operating Officer of Carter Bankshares, Inc. (CARE), reported a sale of 13,550 shares of the issuer's common stock on 09/10/2025 at a reported price of $19.8341 per share. After the transaction, the reporting person beneficially owned 21,909 shares. The Form 4 was submitted by one reporting person and signed by an attorney-in-fact.

Positive

• Reporting person retains a meaningful stake of 21,909 shares after the sale
• Transaction was reported on Form 4, providing transparency about insider activity

Negative

• Insider sold 13,550 shares, reducing direct holdings which may be viewed negatively by some investors
• Sale at $19.8341 per share realized by an executive, but no explanatory context was provided in the filing

Insights

Corporate Governance Expert

TL;DR: Insider sold shares reducing holdings but retains a meaningful stake of 21,909 shares.

The reported sale of 13,550 shares by the SEVP/COO at $19.8341 reduces direct ownership yet leaves the executive with 21,909 shares, indicating continued alignment with shareholders. This Form 4 discloses a single non-derivative sale and does not show acquisitions or option exercises. No plan-based (10b5-1) checkbox was indicated in the provided content. The filing contains straightforward transaction reporting without additional compensatory or corporate-governance events.

Securities Analyst

TL;DR: Reported sale is material for monitoring insider activity but provides no operational or financial performance information.

The disposition of 13,550 shares at $19.8341 is a quantifiable change in insider holdings and may be relevant to investors tracking insider behavior. The remaining beneficial ownership of 21,909 shares quantifies continued exposure to the company's equity. The Form 4 does not disclose proceeds, motive, or any hedging/derivative positions; therefore it should be interpreted strictly as a change in reported ownership, not as commentary on company prospects.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Speare Matthew M.

(Last) (First) (Middle)

1300 KINGS MOUNTAIN RD.

(Street)

MARTINSVILLE VA 24112

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Carter Bankshares, Inc. [ CARE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SEVP, CHIEF OPERATING OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
09/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/10/2025		S		13,550(1)	D	$19.8341	21,909	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Sale of stock - 09/10/2025

Remarks:

	/s/ Jessica R. Sikes, Attorney-in-Fact	09/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did CARE (Carter Bankshares) report?

The SEVP/COO, Matthew M. Speare, reported a sale of 13,550 common shares.

At what price were the CARE shares sold by the insider?

The reported sale price was $19.8341 per share.

How many CARE shares does the insider own after the transaction?

Following the reported sale, the reporting person beneficially owned 21,909 shares.

Was this Form 4 filed by a single reporting person or multiple filers?

The Form 4 was filed by one reporting person.

Does the filing show any derivative transactions or option exercises?

No. The provided Form 4 shows only a non-derivative sale of common stock; no derivatives or exercises are reported.